World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00001891
Date of registration: 03/11/1999
Primary sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Public title: Myocardial Contrast Echocardiography (MCE) to Check for Living and Working Heart Muscle
Scientific title: Assessment of Myocardial Viability Utilizing Myocardial Contrast Echocardiography
Date of first enrolment: May 1999
Target sample size: 200
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00001891
Study type:  Interventional
Study design:  Endpoint Classification: Efficacy Study, Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Key inclusion & exclusion criteria

Patients undergoing evaluation for CAD who show at least two myocardial segments with wall
motion abnormalities on a baseline echocardiogram will be offered to participate in this
study.

Patients will be adults older than 21 years of age.

No pre-menopausal patients who are lactating, are pregnant or potentially pregnant as
judged by history, physical examination, ultrasound or urine pregnancy test.

No one with unstable angina.

No subjects with recent myocardial infarction (less than 1 month).

No one with frequent ectopy which precludes adequate imaging acquisition.

No subjects with significant hypertension (systolic blood pressure greater than 170 mm
Hg).

No hypotension with basal sitting systolic arterial pressure less than 100 mm HG confirmed
30 minutes later.

No subjects with sinus tachycardia greater than or equal to 100 beats/minute.

No atrial fibrillation.

No inadequate two-dimensional echocardiographic windows.



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Coronary Disease
Heart Diseases
Intervention(s)
Procedure: Dobutamine echocardiography
Procedure: Myocardial contrast echocardiography
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
99-H-0108
990108
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history